The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
191 reports and counting
Electra Therapeutics Raises $183 Million in Series C - October 22, 2024
Electra Therapeutics announced $183 Million in Series C funding at a Undisclosed valuation. Electra Therapeutics raised an oversubscribed $183 million Series C to advance clinical trials for novel immunology therapies targeting autoimmune and...
Electra Raises $328M in Series
Electra, a Energy company based in Paris, France, has raised $328M in Series at a $1.2B valuation led by PGGM, Bpifrance.
Electra raises $180.4M Series C
Electra raises $180.4M in Series C. Developing low-carbon steelmaking process using clean electricity for decarbonization...
Electra raises $328M Series at $1.2B valuation
Electra raises $328M in Series at $1.2B valuation. Developing network of ultra-fast charging stations for electric vehicles...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.